Clinical and radiological outcomes following insertion of a novel removable percutaneous interspinous process spacer: an initial experience
- 31 May 2022
- journal article
- research article
- Published by Springer Nature in Neuroradiology
- Vol. 64 (9) , 1887-1895
Abstract
Purpose To evaluate clinical and radiological outcomes of a series of patients treated with a removable percutaneous interspinous process spacer (IPS) (LobsterProject® Techlamed®) for symptomatic degenerative lumbar spinal stenosis (DLSS). Methods All patients treated in two centres with this IPS during 2019 were retrospectively reviewed. Procedures were performed under deep sedation or general anaesthesia by two interventional radiologists. Patients were clinically evaluated before intervention and at 3-month follow-up with Visual Analog Scales for pain (VAS), Oswestry Disability Index (ODI) and radiologically with MRI or CT scans. Neural foramina were independently measured for each patient on pre- and post-procedural CT scans by two radiologists. Results Fifty-nine patients were treated in the selected period of which fifty-eight had complete documentation (mean age 71.2 ± 9.2 years [55–92], 32 males, 26 females). Forty-eight interventions were performed under deep sedation and ten under general anaesthesia, without procedural complications. Clinical follow-up at 3 months showed a significant reduction of pain (VAS from 83 ± 9 to 29 ± 19, − 65%; p < 0.001) and an improvement in functional outcomes (ODI from 31 ± 12 to 13 ± 10%, − 58%; p < 0.001). There was one case of unsatisfactory positioning post procedure, two cases of posterior migration at 3-month follow-up and one case of spinous process fracture. Mean neural foramina area increased from 77 ± 23 to 95 ± 27 mm2 (+ 26%; p < 0.001) with very good inter-observer reliability (Cronbach’s alpha = 0.899). Conclusion Percutaneous minimally invasive insertion of a removable IPS device demonstrates a favourable safety profile, good clinical outcomes at 3 months, and apparent anatomical increase in foraminal dimensions. Trial registration ClinicalTrials.gov Identifier: NCT05203666—Release Date: 21st January 2022, retrospectively registered.Keywords
This publication has 22 references indexed in Scilit:
- X-Stop Versus Decompressive Surgery for Lumbar Neurogenic Intermittent ClaudicationSpine, 2013
- Clinical evaluation of the preliminary safety and effectiveness of a minimally invasive interspinous process device APERIUS® in degenerative lumbar spinal stenosis with symptomatic neurogenic intermittent claudicationEuropean Spine Journal, 2012
- Lumbar spinal stenosis treatment with aperius perclid interspinous systemEuropean Spine Journal, 2012
- Posterior Vertebral Arch Cement Augmentation (Spinoplasty) to Prevent Fracture of Spinous Processes after Interspinous Spacer ImplantAmerican Journal of Neuroradiology, 2011
- Qualitative Grading of Severity of Lumbar Spinal Stenosis Based on the Morphology of the Dural Sac on Magnetic Resonance ImagesSpine, 2010
- A biomechanical study of the instrumented and adjacent lumbar levels after In-Space interspinous spacer insertionJournal of Neurosurgery: Spine, 2010
- Trends, Major Medical Complications, and Charges Associated With Surgery for Lumbar Spinal Stenosis in Older AdultsJAMA, 2010
- Interspinous implants (X Stop®, Wallis®, Diam®) for the treatment of LSS: is there a correlation between radiological parameters and clinical outcome?European Spine Journal, 2009
- The Treatment Mechanism of an Interspinous Process Implant for Lumbar Neurogenic Intermittent ClaudicationSpine, 2005
- Lumbar Spinal Stenosis: Conservative or Surgical Management?Spine, 2000